Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis
- PMID: 33722992
- DOI: 10.1212/WNL.0000000000011839
Incidence and Prevalence of Drug-Resistant Epilepsy: A Systematic Review and Meta-analysis
Abstract
Objective: To evaluate the incidence and prevalence of drug-resistant epilepsy (DRE) as well as its predictors and correlates, we conducted a systematic review and meta-analysis of observational studies.
Methods: Our protocol was registered with PROSPERO, and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses and Meta-analysis of Observational Studies in Epidemiology reporting standards were followed. We searched MEDLINE, Embase, and Web of Science. We used a double arcsine transformation and random-effects models to perform our meta-analyses. We performed random-effects meta-regressions using study-level data.
Results: Our search strategy identified 10,794 abstracts. Of these, 103 articles met our eligibility criteria. There was high interstudy heterogeneity and risk of bias. The cumulative incidence of DRE was 25.0% (95% confidence interval [CI]: 16.8-34.3) in child studies but 14.6% (95% CI: 8.8-21.6) in adult/mixed age studies. The prevalence of DRE was 13.7% (95% CI: 9.2-19.0) in population/community-based populations but 36.3% (95% CI: 30.4-42.4) in clinic-based cohorts. Meta-regression confirmed that the prevalence of DRE was higher in clinic-based populations and in focal epilepsy. Multiple predictors and correlates of DRE were identified. The most reported of these were having a neurologic deficit, an abnormal EEG, and symptomatic epilepsy. The most reported genetic predictors of DRE were polymorphisms of the ABCB1 gene.
Conclusions: Our observations provide a basis for estimating the incidence and prevalence of DRE, which vary between populations. We identified numerous putative DRE predictors and correlates. These findings are important to plan epilepsy services, including epilepsy surgery, a crucial treatment option for people with disabling seizures and DRE.
© 2021 American Academy of Neurology.
Similar articles
-
The epidemiology of drug-resistant epilepsy: A systematic review and meta-analysis.Epilepsia. 2018 Dec;59(12):2179-2193. doi: 10.1111/epi.14596. Epub 2018 Nov 13. Epilepsia. 2018. PMID: 30426482
-
Risk factors for drug-resistant epilepsy: A systematic review and meta-analysis.Medicine (Baltimore). 2019 Jul;98(30):e16402. doi: 10.1097/MD.0000000000016402. Medicine (Baltimore). 2019. PMID: 31348240 Free PMC article.
-
Predictors of drug-resistant epilepsy in childhood epilepsy syndromes: A subgroup analysis from a prospective cohort study.Epilepsia. 2024 Oct;65(10):2995-3009. doi: 10.1111/epi.18100. Epub 2024 Aug 16. Epilepsia. 2024. PMID: 39150742
-
Drug-resistant epilepsy in Saudi Arabia: prevalence, predictive factors, and treatment outcomes.BMC Neurol. 2025 Apr 5;25(1):143. doi: 10.1186/s12883-025-04149-w. BMC Neurol. 2025. PMID: 40188014 Free PMC article.
-
Predictive factors of drug-resistant epilepsy in children presenting under 2 years of age: experience of a tertiary center in Turkey.Acta Neurol Belg. 2018 Mar;118(1):71-75. doi: 10.1007/s13760-017-0850-3. Epub 2017 Oct 23. Acta Neurol Belg. 2018. PMID: 29063291
Cited by
-
Curcumin attenuated neuroinflammation via the TLR4/MyD88/NF-κB signaling way in the juvenile rat hippocampus following kainic acid-induced epileptic seizures.Metab Brain Dis. 2024 Oct;39(7):1387-1403. doi: 10.1007/s11011-024-01401-z. Epub 2024 Sep 18. Metab Brain Dis. 2024. PMID: 39292432
-
Invasive neuromodulation for epilepsy: Comparison of multiple approaches from a single center.Epilepsy Behav. 2022 Dec;137(Pt A):108951. doi: 10.1016/j.yebeh.2022.108951. Epub 2022 Oct 27. Epilepsy Behav. 2022. PMID: 36327647 Free PMC article.
-
Exercise in patients with epilepsy and neurostimulation devices - physical activity levels, barriers, and beliefs.Epilepsy Behav Rep. 2024 Jul 29;27:100699. doi: 10.1016/j.ebr.2024.100699. eCollection 2024. Epilepsy Behav Rep. 2024. PMID: 39188780 Free PMC article.
-
Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy.Front Pharmacol. 2023 Nov 15;14:1209815. doi: 10.3389/fphar.2023.1209815. eCollection 2023. Front Pharmacol. 2023. PMID: 38035012 Free PMC article.
-
Beneficial Effects of Capsaicin in Disorders of the Central Nervous System.Molecules. 2022 Apr 12;27(8):2484. doi: 10.3390/molecules27082484. Molecules. 2022. PMID: 35458680 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous